Silence Therapeutics Plc (SLNCF)
Q2 2020 Results Conference Call
September 14, 2020 8:00 AM ET
Company Participants
Gem Hopkins - Head, IR and Corporate Communications
Iain Ross - Chairman
Mark Rothera - President & CEO
Giles Campion - Head of R&D and Chief Medical Officer
Rob Quinn - Chief Financial Officer
Conference Call Participants
Patrick Trucchio - H.C. Wainwright
Jens Lindqvist - Investec
Miles Dixon - Peel Hunt
Presentation
Gem Hopkins
Good morning and good afternoon, and thank you for joining us for the Silence Therapeutics Half Year 2020 Results Call. Having recently joined Silence's